Physician profile
Grace Kobusingye
NPI 1487609418
$956.11
in general payments reported to CMS, 2019-2025
14 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $12.30 · 2021: $101 · 2022: $110 · 2023: $207 · 2024: $229 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $229.35 | 2019-2025 | Vaxneuvance, Rotateq, Vaxelis |
| Pfizer INC. | $213.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $119.37 | 2019-2024 | Bexsero |
| Sanofi Pasteur INC. | $65.84 | 2023-2025 | |
| Alk-Abello, INC | $58.54 | 2024-2025 | Neffy, Odactra, Grastek |
| Cranial Technologies, INC | $56.31 | 2021-2023 | Doc Band |
| Kaleo, INC. | $48.16 | 2021-2024 | Auvi-Q |
| Ironshore Pharmaceuticals INC. | $39.15 | 2019 | |
| Tris Pharma INC | $35.63 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $30.16 | 2023-2024 | Qelbree, Qelbree |
| Neurelis, INC. | $17.92 | 2024 | Valtoco |
| Shire North American Group INC | $16.03 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.77 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Kobusingye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.